Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 18 to 75

Using metformin to improve fibromyalgia symptoms

Official title: Metformin as a Novel, Mechanistic Treatment of Fibromyalgia; a Proof of Concept RCT

Run by University of Utah · NCT05900466 · Data updated 2026-11-12

This study is testing if low-dose metformin can help people with fibromyalgia feel better compared to a placebo.

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment72 (estimated)
SponsorUniversity of Utah
Academic / other
Locations1 site (Salt Lake City, Utah)
StatusRecruiting
StartedApril 1, 2023
Main results expectedMarch 31, 2027
Study endsMarch 31, 2027
Registry record updatedMarch 30, 2026
Trial IDNCT05900466 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults diagnosed with fibromyalgia syndrome who meet specific classification criteria and can adhere to a medication regimen.

Probably not a fit

Patients with co-occurring progressive diseases, diabetes, or serious psychopathology may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to evaluate the safety and efficacy of low-dose metformin in improving symptoms associated with fibromyalgia syndrome (FMS). The study hypothesizes that patients receiving metformin will experience greater symptom relief compared to those on a placebo. The approach focuses on modulating neuroinflammatory pathways, which are believed to contribute to the chronic pain experienced by FMS patients. By targeting these pathways, the study seeks to provide a more effective treatment option for a condition that currently has limited therapeutic success.

Why it matters

Potential benefit: If successful, this treatment could significantly improve the quality of life for patients suffering from fibromyalgia by alleviating their symptoms more effectively than current therapies.

How similar studies have gone: While the use of metformin for fibromyalgia is a novel approach, preclinical studies have shown promise in treating related symptoms, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* To be able to follow the protocol in English
* Fibromyalgia Syndrome: Participant must meet the American College of Rheumatology 2016 revised classification criteria for Fibromyalgia
* Ability to take oral medication and be willing to adhere to the metformin regimen (once daily)

Exclusion Criteria:

* Co-occurring progressive disease (self-report, physician-diagnosed)
* Diabetes
* Pregnancy or planning to be pregnant in the next year (all premenopausal participants will be tested)
* Having known cardiovascular, liver, kidney or pulmonary diseases (self-report, physician-diagnosed)
* Having known serious psychopathology (Clinician diagnoses of psychosis, organic mental disorder, or dissociative disorder, self-reported active suicidal intent, self-reported history of inpatient admission to a psychiatric ward in the past year, evidence or self-report of self-injurious behaviors in the past year, reported current or recent history (2years) of non-IV substance abuse, any history of recreational IV drug use)
* Having autoimmune disorder (e.g., rheumatoid arthritis) (self-report, physician-diagnosed)
* Having neuropathic pain (self-report, physician-diagnosed)
* Having pain associated with a terminal illness, acute pain, pain associated with specific organ damage (eg, stomach ulcer) (self-report, physician-diagnosed)
* Concurrent use of weight controlling medications (eg, Xenical)
* Requiring an interpreter to communicate
* Abnormal levels of creatinine, vitamin B12, or hepatic function panel
* eGFR of below 45mL/min/1.73m2

Where it's running

  • University of Utah
    Salt Lake City, Utah, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.